-
Calendar of Events
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Enzon Pharmaceuticals Inc.s financial performance into perspective.
Calendar of Events
Upcoming Events Details on upcoming events are not yet available. Please click here to be notified of all upcoming events.
Archived Events Feb 17, 2010
10:00 AM ETFourth Quarter Earnings Call 
Listen to webcast 
Additional Information Nov 3, 2009
10:00 AM ETThird Quarter Earnings Call Listen to webcast Aug 5, 2009
9:30 AM ET2009 BMO Capital Markets 9th Annual Focus on Healthcare Conference
Speaker: Jeffrey H. Buchalter, President & CEOListen to webcast Aug 4, 2009
9:00 AM ETSecond Quarter Earnings Call Listen to webcast Jun 23, 2009
2:00 PM ETPEG SN38 Phase II Initiation Listen to webcast May 7, 2009
10:00 AM ETFirst Quarter Earnings Call Listen to webcast Feb 19, 2009
10:00 AM ETFourth Quarter Earnings Call Listen to webcast Additional Information Aug 6, 2008
9:00 AMSecond Quarter Earnings Call Listen to webcast May 7, 2008
10:00 AMFirst Quarter Earnings Call Listen to webcast Oct 30, 2007
8:30 AM ETEnzon Investor Day Listen to webcast Aug 2, 2007
10:00 AMSecond Quarter Earnings Call Listen to webcast Mar 12, 2007
1:40 PMCowen and Company 27th Annual Healthcare Conference Feb 13, 2007
10:00 AMFourth Quarter Earnings Call Listen to webcast
= add file to Briefcase
| (ENZN) NASDAQ | |
| Last Trade | 9.850 |
| Change(%) |
0.04
|
| Volume | 651,900 |
| Mar 9, 2010 3:59 PM ET | |
Sign up to receive Enzon Pharmaceuticals Inc. financial information by email.
News
-
Details on upcoming events are not yet available.
click here to be notified of all upcoming events.
-
02-17-2010
Fourth Quarter Earnings Call
-
11-03-2009
Third Quarter Earnings Call
-
08-05-2009
2009 BMO Capital Markets 9th Annual Focus on Healthcare Conference
-
08-04-2009
Second Quarter Earnings Call
-
Really Simple Syndication is a format designed for sharing web content such as headlines. An RSS feed highlights fresh material for you, so you don't have to repeatedly check a site yourself for updates.
-
03-08-2010
Enzon's Debt is Reduced by $116 Million
--Debt converted into an additional 13.5 million shares--
-
02-24-2010
Enzon Opens Pediatric Study of PEG-SN38
-
02-22-2010
Enzon Board of Directors Appoints Executive Committee
Jeffrey Buchalter Steps Down as CEO of Enzon
-
02-17-2010
Enzon Reports 2009 Results
--Sale of Specialty Pharmaceutical Business brings over $300 million in value--